Explore our pipeline of therapies targeting underserved areas of ophthalmology:
- OCU400For treatment of Inherited Retinal Disorders
- OCU410For treatment of Dry Age-Related Macular Degeneration
- OCU200For treatment of Neovascular Disorders
Potential to provide one treatment option for all forms of Retinitis Pigmentosa
Addressing one of the most common eye diseases among people over 50, which causes blurred or reduced central vision, due to thinning of the macula
Learn More About OCU410Addressing the leading cause of vision loss in people over the age of 60, where abnormal blood vessels grow under the retina and leak blood and proteins.
Learn More About OCU200Explore our pipeline of therapies targeting underserved areas of ophthalmology:
Potential to provide one treatment option for all forms of Retinitis Pigmentosa
Learn More About OCU400Addressing one of the most common eye diseases among people over 50, which causes blurred or reduced central vision, due to thinning of the macula
Learn More About OCU410
